Why some people do not respond to psychedelics - receptor biology, metabolism, medication interactions, and set-and-setting all shape psychedelic effects

Psychedelic non-response can arise from several interacting factors, including brain receptor differences, rapid drug metabolism, medication effects, dose variability, and psychological context. Serotonergic psychedelics such as psilocybin and LSD may feel weak or absent in some people when 5-HT2A signaling is reduced, while other compounds like MDMA or ketamine can also vary widely across individuals. Antidepressants, especially SSRIs, are often discussed as a major reason for blunted effects, but biology is only part of the picture. Expectations, anxiety, dissociation, prior exposure, and the reliability of the substance itself can all shape whether an experience feels noticeable or therapeutic. Individual variation matters for both safety and treatment design. Better screening, careful dose selection, attention to medication interactions, and realistic expectations can help explain why psychedelic experiences are sometimes unexpectedly mild or absent.